Active-ingredient Dossier
Famciclovir
Active-ingredient Dossier for Famciclovir (antiviral agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: FAMVIR
- Brand: FAMCICLOVIR-
- Brand: APO-FAMCICLOVIR
- Brand: ELOVAX
- Brand: EZOVIR
- Brand: FAMCICLOVIR- WGR
- Therapeutic area: Infectious Disease
What is
Famciclovir Famciclovir is an antiviral agent.
Australian brands containing
Famciclovir — FAMVIR — FAMCICLOVIR- — APO-FAMCICLOVIR — ELOVAX — EZOVIR — FAMCICLOVIR- WGR — FAVIC
Therapeutic areas
Famciclovir is registered in Infectious Disease, with 19 brands containing the ingredient on the ARTG.
Sponsor landscape
Famciclovir is marketed by six sponsors: Arrotex Pharmaceuticals, Atnahs Pharma, Neo Health (OTC), GM Pharma, Southern Cross Pharma, and Noumed Pharmaceuticals.
PBS and regulatory activity
One brand containing famciclovir has PBS-listed items, with the latest PBS schedule date of 1 May 2026. In the 2013–14 financial year, famciclovir products generated government expenditure of $40.7 million across 197,597 scripts. The latest PBAC outcome on record is from 1 November 2006, and no AusPARs are recorded for this ingredient.